Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

Similar articles for PubMed (Select 20200384)

1.

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL.

N Engl J Med. 2010 Mar 4;362(9):800-11. doi: 10.1056/NEJMoa0908359.

2.

Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography.

Silbernagel G, Grammer TB, Winkelmann BR, Boehm BO, März W.

Diabetes Care. 2011 Jun;34(6):1355-61. doi: 10.2337/dc10-2010. Epub 2011 Apr 22.

4.

Relationship of initial glucose level and all-cause death in patients with ischaemic stroke: the roles of diabetes mellitus and glycated hemoglobin level.

Hu GC, Hsieh SF, Chen YM, Hsu HH, Hu YN, Chien KL.

Eur J Neurol. 2012 Jun;19(6):884-91. doi: 10.1111/j.1468-1331.2011.03647.x. Epub 2012 Jan 31.

PMID:
22289016
5.

Psychological distress, glycated hemoglobin, and mortality in adults with and without diabetes.

Hamer M, Stamatakis E, Kivimäki M, Pascal Kengne A, Batty GD.

Psychosom Med. 2010 Nov;72(9):882-6. doi: 10.1097/PSY.0b013e3181f6696e. Epub 2010 Sep 30.

PMID:
20884891
6.

Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.

Selvin E, Rawlings AM, Grams M, Klein R, Sharrett AR, Steffes M, Coresh J.

Lancet Diabetes Endocrinol. 2014 Apr;2(4):279-88. doi: 10.1016/S2213-8587(13)70199-2. Epub 2014 Jan 15.

7.

The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study.

Matsushita K, Blecker S, Pazin-Filho A, Bertoni A, Chang PP, Coresh J, Selvin E.

Diabetes. 2010 Aug;59(8):2020-6. doi: 10.2337/db10-0165. Epub 2010 May 18.

8.

Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes.

Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, Astor BC, Sharrett AR, Brancati FL, Coresh J.

Diabetes. 2011 Jan;60(1):298-305. doi: 10.2337/db10-1198. Epub 2010 Oct 26.

9.

Glycated hemoglobin and cancer incidence and mortality in the Atherosclerosis in Communities (ARIC) Study, 1990-2006.

Joshu CE, Prizment AE, Dluzniewski PJ, Menke A, Folsom AR, Coresh J, Yeh HC, Brancati FL, Platz EA, Selvin E.

Int J Cancer. 2012 Oct 1;131(7):1667-77. doi: 10.1002/ijc.27394. Epub 2012 Feb 10.

11.

No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes.

Selvin E, Rawlings AM, Bergenstal RM, Coresh J, Brancati FL.

Diabetes Care. 2013 Oct;36(10):2995-3001. doi: 10.2337/dc12-2715. Epub 2013 May 30.

12.

Effects of intensive glucose lowering in type 2 diabetes.

Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT.

N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.

13.

[Performance of glycated hemoglobin and a risk model for detection of unknown diabetes in coronary patients].

de la Hera JM, Vegas JM, Hernández E, Lozano I, García-Ruiz JM, Fernández-Cimadevilla OC, Carro A, Avanzas P, Torres F, Bayón J, Menéndez T, Jiménez-Navarro M, Delgado E.

Rev Esp Cardiol. 2011 Sep;64(9):759-65. doi: 10.1016/j.recesp.2011.03.034. Epub 2011 Jul 12. Spanish.

14.

Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes.

Xu L, Chan WM, Hui YF, Lam TH.

Diabet Med. 2012 Mar;29(3):393-8. doi: 10.1111/j.1464-5491.2011.03456.x.

PMID:
21916977
15.

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.

Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N.

Ann Intern Med. 2004 Sep 21;141(6):413-20.

PMID:
15381514
16.

Glycated hemoglobin as a marker of cardiovascular risk.

Khaw KT, Wareham N.

Curr Opin Lipidol. 2006 Dec;17(6):637-43. Review.

PMID:
17095908
17.

Alternative markers of hyperglycemia and risk of diabetes.

Juraschek SP, Steffes MW, Miller ER 3rd, Selvin E.

Diabetes Care. 2012 Nov;35(11):2265-70. doi: 10.2337/dc12-0787. Epub 2012 Aug 8.

18.
19.

Long-term effects of intensive glucose lowering on cardiovascular outcomes.

ACCORD Study Group, Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, Probstfield JL, Cushman WC, Ginsberg HN, Bigger JT, Grimm RH Jr, Byington RP, Rosenberg YD, Friedewald WT.

N Engl J Med. 2011 Mar 3;364(9):818-28. doi: 10.1056/NEJMoa1006524.

20.

Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study.

Wang H, Shara NM, Lee ET, Devereux R, Calhoun D, de Simone G, Umans JG, Howard BV.

Diabetes Care. 2011 Sep;34(9):1952-8. doi: 10.2337/dc11-0329. Epub 2011 Jul 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk